VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Compagnie Financiere Richemont SA vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Compagnie Financiere Richemont SA
CFR · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Compagnie Financiere Richemont SA's moat claims, evidence, and risks.
View CFR analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 84 / 100 for Compagnie Financiere Richemont SA).
- Segment focus: Compagnie Financiere Richemont SA has 3 segments (71.6% in Jewellery Maisons); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Compagnie Financiere Richemont SA has 4 moat types across 2 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Compagnie Financiere Richemont SA
Jewellery Maisons
Luxury jewellery (branded fine jewellery & high jewellery)
Global
Affluent and high-net-worth consumers
Brand owner, manufacturer and direct-to-client retailer
71.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Compagnie Financiere Richemont SA strengths
Novo Nordisk A/S strengths
Segment mix
Compagnie Financiere Richemont SA segments
Full profile >Jewellery Maisons
Oligopoly
Specialist Watchmakers
Oligopoly
Other (Fashion & Accessories, Watchfinder, ancillary)
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.